Daily Archives: November 5, 2021

Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients with Crohn’s Disease

Mirikizumab is a humanized monoclonal antibody targeting IL-23p19 with demonstrated efficacy in psoriasis and ulcerative colitis. We investigated the safety and efficacy of mirikizumab in patients with moderate-to-severe Crohn’s disease (CD). Continue reading

Posted in News | Comments Off on Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients with Crohn’s Disease

Correction

Jin B, Ha SE, Wei L, et al. Colonic Motility Is Improved by the Activation of 5-HT2B Receptors on Interstitial Cells of Cajal in Diabetic Mice. Gastroenterology 2021;161:608–622. Continue reading

Posted in News | Comments Off on Correction

CME Exam 2: Global Incidence of Acute Pancreatitis is Increasing Over Time: A Systematic Review and Meta-Analysis

Posted in News | Comments Off on CME Exam 2: Global Incidence of Acute Pancreatitis is Increasing Over Time: A Systematic Review and Meta-Analysis